Mostrando 10 resultados de: 57
Publisher
American Journal of Therapeutics(20)
Revista Latinoamericana de Hipertension(14)
Current Pharmaceutical Design(5)
Vessel Plus(4)
Archivos Venezolanos de Farmacologia y Terapeutica(3)
Área temáticas
Enfermedades(43)
Fisiología humana(27)
Farmacología y terapéutica(20)
Salud y seguridad personal(14)
Medicina y salud(9)
Área de conocimiento
Enfermedad cardiovascular(15)
Medicina interna(15)
Fisiología(9)
Diabetes(7)
Obesidad(7)
Haemodynamical variables versus endothelial hormones in hypertensive and type 2 diabetic patients with endothelial dysfunction
ArticleAbstract: Leptin is a 167 aminoacid peptidic hormone secreted by adipose tissue. It works mainly in the hypothPalabras claves:C reactive protein, Hypertension, leptin, Nitric oxide, Type 2 Diabetes mellitusAutores:Cano R.A., Contreras F., Fouillioux C., González M.C., Gotera D., Lares M., Magaldi L., Mayda C.L., Pacheco B., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusEnergetic metabolism in cardiomyocytes: molecular basis of heart ischemia and arrhythmogenesis
ReviewAbstract: Cardiac muscle contraction is a strictly regulated process which conjugates a series of electrophysiPalabras claves:Arrhythmias, cardiomyocyte, ischemia, myocardial infarction, Myocardial metabolismAutores:Chávez-Castillo M., García A., Luzardo E., Martínez M.S., Olivar L.C., Quintero J.J.R., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopusEpidemiological behavior of high -sensitivity C-Reactive Protein (hs-CRP) in adult individuals in the Maracaibo city, Venezuela
ArticleAbstract: Objectives: High-sensitivity C-Reactive Protein (hs-CRP) is one of the most applied inflammation marPalabras claves:C-Reactive protein, Cardiovascular disease, Low-grade inflammation, Metabolic syndrome, RISK FACTORSAutores:Aguirre M.A., Añez-Ramos R., Apruzzese V., Bello L.M., Cabrera M., Chávez-Castillo M., Fuenmayor D., González M.C., Marcano R.P., Martínez M.S., Mendoza L., Montiel M., Nava A., Pachano F., Rincón T., Rojas-Quintero J., Salazar-Vílchez J., Toledo A.C., Torres Y., Valmore Bermúdez, Velasco M., Villalobos M.Fuentes:scopusEpidemiological behavior of subclinical hypothyroidism and its association with cardiometabolic risk factors in adult Municipality Maracaibo, Venezuela
ArticleAbstract: Introduction: the relationship between subclinical hypothyroidism (HSC) and several cardiovascular rPalabras claves:Cardiovascular Risk Factors, diabetes mellitus, Metabolic syndrome, Subclinical hypothyroidism, TshAutores:Aguirre M.A., Añez-Ramos R., Cabrera M., Cano-Ponce C., Chávez C., David A., De M.C.G., González M.C., Gonzalez R., Iriarte N., Lubo A., Marulanda F., Miquilena E., Pachano F., París R., Paz P., Rojas-Quintero J., Salazar-Vílchez J., Toledo A.C., Valmore Bermúdez, Velasco M.Fuentes:scopusErratum: Energetic metabolism in Cardiomyocytes: Molecular basis of heart ischemia and arrhythmogenesis (Vessel Plus (2017) 1 (230-241) DOI: 10.20517/2574-1209.2017.34)
OtherAbstract: The original article was published on 28 Dec 2017. After the publication of the article named “EnergPalabras claves:Autores:Chávez-Castillo M., García A., Luzardo E., Martínez M.S., Olivar L.C., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopusExploring phytotherapeutic alternatives for obesity, insulin resistance and diabetes mellitus
ReviewAbstract: At present, the pathologic spectrum of obesity-insulin resistance (IR)-diabetes mellitus (DM) repre-Palabras claves:Cardiovascular disease, diabetes mellitus, Insulin Resistance, Medicinal herbs, obesity, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Nuñez V., Ortega A., Pírela D., Rojas M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusEffect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects
ArticleAbstract: Dopamine agonists play an important role in the regulation of the central nervous-cardiovascular, rePalabras claves:dopamine, Dopaminergic agonists, Dopaminergic receptors, Hypertension, Insulin, Type 2 Diabetes mellitusAutores:Bolívar H., Cano R.A., Contreras F., Foullioux C., Lares M., Leal E.M., Maroun C., Pacheco B., Valmore Bermúdez, Velasco M.Fuentes:scopusEffects of metoclopramide and metoclopramide/dopamine on blood pressure and insulin release in normotensive, hypertensive, and type 2 diabetic subjects
ArticleAbstract: The objective is to determine cardiovascular and insulin release effects under metoclopramide (MTC)Palabras claves:dopamine, Dopamine receptors, Hypertension, Insulin release, Metoclopramide, Type 2 DiabetesAutores:Bolívar H., Cano R.A., Contreras F., Fouillioux C., González M.C., Hernández-Hernandez R., Lares M., Valmore Bermúdez, Velasco M.Fuentes:scopusDetermination of Non-HDL cholesterol in diabetic and hypertensive patients
ArticleAbstract: Recently, it has been suggested that non-high-density lipoprotein (non-HDL) cholesterol measure is aPalabras claves:atherosclerosis, LDL, Non-HDL cholesterolAutores:Castro J., Contreras F., Dowling V., González M.C., Guerra-Torres X.E., Lares M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusDirect renin inhibitors as antihypertensive agents
ReviewAbstract: Hypertension, a serious disease affecting almost a billion people (25% of adults) worldwide, is a maPalabras claves:Aliskiren, angiotensin II, Coronary heart disease, Hypertension, ReninAutores:Israili Z.H., Valmore Bermúdez, Velasco M.Fuentes:scopus